By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


GW Pharmaceuticals Ltd. 

Porton Down Science Park

Salisbury  Wiltshire  SP4 0JQ  United Kingdom
Phone: 44-1980-619000 Fax: +44-1980-619111



Company News
GW Pharmaceuticals (GWPH) To Report Q1, 2015 Financial Results And Host Conference Call On 4 February, 2015 1/27/2015 7:33:45 AM
GW Pharmaceuticals (GWPH) And Otsuka Pharmaceutical Co., Ltd. Announce Results In First Of Three Sativex® Phase 3 Cancer Pain Trials 1/8/2015 8:34:21 AM
GW Pharmaceuticals (GWPH) Provides Update On Epidiolex® Program In Treatment Resistant Childhood Epilepsies 1/8/2015 8:18:30 AM
GW Pharmaceuticals (GWPH) Falls as Cannabis Drug Fails Key Cancer Pain Study 1/8/2015 6:29:39 AM
GW Pharmaceuticals Added To NASDAQ Biotechnology Index 12/22/2014 7:29:55 AM
GW Pharmaceuticals To Present At The 26th Annual Piper Jaffray Healthcare Conference 11/26/2014 11:00:53 AM
GW Pharmaceuticals To Report Q4, Year-End 2014 Financial Results And Host Conference Call On 2 December, 2014 11/24/2014 12:56:59 PM
GW Pharmaceuticals To Present At The Jefferies and Co. 2014 Global Healthcare Conference 11/17/2014 4:22:59 PM
GW Pharmaceuticals Commences Phase 2/3 Clinical Trial Of Epidiolex® As A Potential Treatment For Epilepsy In Dravet Syndrome 10/30/2014 7:26:21 AM
GW Pharmaceuticals Announces Epidiolex® Receives Orphan Designation From European Medicines Agency For The Treatment Of Dravet Syndrome 10/22/2014 7:13:35 AM